Search results
Results from the WOW.Com Content Network
CBS News documented how Steward, along with private equity investors, extracted hundreds of millions of dollars from that company, potentially leading to shortages of life-saving medical equipment.
Gastroesophageal reflux disease (GERD) or gastro-oesophageal reflux disease (GORD) is a chronic upper gastrointestinal disease in which stomach content persistently and regularly flows up into the esophagus, resulting in symptoms and/or complications.
The software shortens the time from news event to news distribution. [8] In 2007, the firm introduced VerticalNews. [4] The firm also adopted site licenses, including the ability for users to download reports showing the types of information used in a given organization—information previously restricted to the NewsRx staff. [8]
The drug, suzetrigine, received the FDA's official stamp of approval Thursday to be sold as a 50-milligram prescription pill taken every 12 hours, according to a press release.
Insys Therapeutics Company type Public Traded as Nasdaq: INSY Industry Pharmaceutical Founded 1990 ; 35 years ago (1990) Founder John Kapoor Fate Bankrupt (2019) Headquarters Chandler, Arizona, U.S. Key people Michael Babich (CEO) Products Subsys (fentanyl) Syndros (Tetrahydrocannabinol) Number of employees 343 (2019) Insys Therapeutics was an American specialty pharmaceutical company based in ...
The looming introduction of a shorter settlement cycle for U.S. securities is causing headaches for international fund managers, who face staffing problems, the prospect of holding more cash and ...
Most of these medications are benzimidazole derivatives, related to omeprazole, but imidazopyridine derivatives such as tenatoprazole have also been developed. [77] Potassium-competitive inhibitors such as revaprazan reversibly block the potassium-binding site of the proton pump, acting more quickly, but are not available in most countries.
Amantadine was initially developed to prevent replication of the influenza A virus. [18] Its main clinical use today is treatment of Parkinson's disease. [18] Other uses include treatment of drug-induced extrapyramidal side effects, motor fluctuations during levodopa therapy in Parkinson's disease, traumatic brain injury, and autistic spectrum disorders.